TCTR20210617001招募中4 期
Effect of vancomycin loading dose on AUC0-24 target attainment in pediatric sepsis patients
Kritsaporn Sujjavorakul0 个研究点目标入组 78 人开始时间: 2021年6月17日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 78
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3 Months 至 18 Years（—）
- 性别
- All
入选标准
- •1. Age 3 months to 18 years at the day of the first dose vancomycin
- •2. Pediatric sepsis patients
- •3. Informed consent by one parent or the legal guardian
排除标准
- •1. Receiving extracorporeal organ support including hemodialysis, peritoneal dialysis (PD), continuous renal replacement therapy (CRRT), plasmapheresis, blood purification, artificial liver support systems, and extracorporeal membrane oxygenation (ECMO)
- •2. Previous vancomycin treatment within 1 weeks prior to the day of study in subject with normal kidney function at baseline or within 4 weeks prior to the day of study in subject with renal impairment.
研究者
相似试验
进行中（未招募）
1 期
investigation on blood-levels and excretion of vancomycin (antibiotictherapy) in dependency on certain parameters (renal function, age, sexetc.) and the kind of infusion. Investigation on the influence of vancomycinon the gut floraIn patients who receive an antibiotic therapy with vancomycin i.v. (because of an infection) blood-, urine and stool samples are taken at certain time points and data on the pharmakokinetic of vancomycin are raised.EUCTR2015-003171-29-DEniversitätsklinikum Tübingen50
招募中
2 期
Optimizing vancomycin dosing in septic patientsIRCT20100228003449N24Tehran University of Medical Sciences40
招募中
不适用
Impact of vancomycin pharmacokinetic properties on treatment outcome in Staphylococcus aureus infectioCertain infectious and parasitic diseasesKCT0001082Seoul National University Bundang Hospital230
已完成
不适用
Impact of neoplasm to vancomycin trough concentrations ~Preliminary investigation targeting the entire concentration range of vancomycin trough value~Infection with MRSAJPRN-UMIN000033265Shujitsu University78
已完成
不适用
Evaluation of a new vancomycin dosage guideline in pediatric oncology patients.Antibioticum therapie10004018NL-OMON40472Academisch Medisch Centrum50